Epidemiološke karakteristike multiple skleroze u Bosni i Hercegovini

Alajbegović, Azra; Alajbegović, Salem; Đelilović-Vranić, Jasminka
February 2011
Medicinski Glasnik;Feb2011, Vol. 8 Issue 1, p56
Academic Journal
No abstract available.


Related Articles

  • Relationships between information processing, depression, fatigue and cognition in multiple sclerosis. Diamond, Bruce J.; Johnson, Susan K.; Kaufman, Michael; Graves, Linda // Archives of Clinical Neuropsychology;Mar2008, Vol. 23 Issue 2, p189 

    Abstract: The neurobehavioral sequelae of multiple sclerosis (MS) consistently include fatigue, depression and cognitive dysfunction with slower processing figuring prominently. However, processing speed is often confounded with accuracy and the relative contributions of depressed mood and...

  • Quality of life, depression and fatigue in mildly disabled patients with relapsing�remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. Patti, F.; Amato, M. P.; Trojano, M.; Bastianello, S.; Tola, M. R.; Picconi, O.; Cilia, S.; Cottone, S.; Centonze, D.; Gasperini, C. // Multiple Sclerosis Journal;Aug2011, Vol. 17 Issue 8, p991 

    Background: The precise relationships among quality of life, depression, fatigue and cognitive impairment in multiple sclerosis (MS) are complex and poorly understood.Objective: To assess the effects of subcutaneous interferon beta-1a on quality of life, depression and fatigue over 3�years...

  • Multipl Sklerozlu Hastalarda Depresyon ve Kognitif Fonksiyon BozukluÄŸu Sıklı287;nın Belirlenmesi. Bilgi, Emine; Hüseyin Özdemir, Hasan; Bulut, Serpil // Turkish Journal of Neurology / Turk Noroloji Dergisi;Mar2013, Vol. 19 Issue 1, p11 

    Objective: Multiple sclerosis (MS) not only leads to different levels of disabilities in mobility and functional activities, but also creates severe disability and impairs the quality of life by limiting the patient's social and occupational life. Most MS patients experience depression. In...

  • Research Notes. Schubert, Charlotte; Lo, Pierrette // Nature Medicine;Aug2003, Vol. 9 Issue 8, p1002 

    Reports on research developments in medical sciences, compiled as of August 2003. Delivery of a gene encoding a human clotting factor to its intended target, liver cells; Testing of multiple sclerosis patients for the presence of serum antibodies against two proteins; Individuals susceptible to...

  • Aricept for MS memory loss.  // Inside MS;Oct-Dec2003, Vol. 21 Issue 4, p38 

    Reports on a study conducted by researchers in Stony Brook, New York, which suggested that oral drug Aricept can modestly improve cognitive impairment in people with multiple sclerosis.

  • Genetic variation in the myeloperoxidase gene and cognitive impairment in Multiple Sclerosis. Manna, I.; Valentino, P.; La Russa, A.; Condino, F.; Nisticò, R.; Liguori, M.; Clodomiro, A.; Andreoli, V.; Pirritano, D.; Cittadella, R.; Quattrone, A. // Journal of Negative Results in Biomedicine;2006, Vol. 5, p3 

    There is evidence that multiple sclerosis (MS) may associated with cognitive impairment in 25 to 40% of cases. The gene encoding myeloperoxidase (MPO) is involved in molecular pathways leading to β-amyloid deposition. We investigated a functional biallelic (G/A) polymorphism in the promoter...

  • RELATIONSHIP BETWEEN DATA COLLECTED DURING THE INTERVIEW AND AUDITORY PROCESSING DISORDER. Fridlin, Sheila Lindenbojm; Pereira, Liliane Desgualdo; Perez, Ana Paula // Revista CEFAC;mar/abr2014, Vol. 16 Issue 2, p405 

    Purpose: the aim of this study was to attempt to correlate data from auditory processing with the data collected during the interview of children and teenagers. Method: we analyzed the information from medical records of 51 patients of both genders, ages 5 to 20 years, assisted at the auditory...

  • Routine Depression Screening in an MS Clinic and Its Association with Provider Treatment Recommendations and Related Treatment Outcome. Stepleman, L.; Penwell-Waines, L.; Rollock, M.; Casillas, R.; Brands, T.; Campbell, J.; Ange, B.; Waller, J. // Journal of Clinical Psychology in Medical Settings;Dec2014, Vol. 21 Issue 4, p347 

    Depression, a frequent concomitant disorder in multiple sclerosis (MS), can impact MS treatment adherence and quality of life. Depression screening in MS care settings may facilitate needed intervention when providers are responsive to screening findings. This study sought to examine the...

  • Depression, disability and cognitive impairment in multiple sclerosis: a cross sectional Italian study. Mattioli, Flavia; Bellomi, Fabio; Stampatori, Chiara; Parrinello, Giovanni; Capra, Ruggero // Neurological Sciences;Oct2011, Vol. 32 Issue 5, p825 

    The disability, cognitive impairment, fatigue and depression are interacting features in multiple sclerosis (MS), whose relation is still unclear. The objective of this study was to evaluate in a sample of MS patients, the frequency of depressive symptoms, its predicting factors and relation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics